BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26202245)

  • 21. Role of lipid metabolism in hepatitis C virus assembly and entry.
    Popescu CI; Dubuisson J
    Biol Cell; 2009 Oct; 102(1):63-74. PubMed ID: 19857204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.
    Sun HY; Lin CC; Tsai PJ; Tsai WJ; Lee JC; Tsao CW; Cheng PN; Wu IC; Chiu YC; Chang TT; Young KC
    Cell Microbiol; 2017 Apr; 19(4):. PubMed ID: 27665576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.
    Fan H; Qiao L; Kang KD; Fan J; Wei W; Luo G
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28404852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.
    Li Z; Li Y; Bi Y; Zhang H; Yao Y; Li Q; Cun W; Dong S
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28539442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus: a new class of virus associated with particles derived from very low-density lipoproteins.
    Ye J
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1099-103. PubMed ID: 22517369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of hepatitis C virus glycoproteins with apolipoproteins E and B early in assembly is conserved in lipoviral particles.
    Boyer A; Dumans A; Beaumont E; Etienne L; Roingeard P; Meunier JC
    J Biol Chem; 2014 Jul; 289(27):18904-13. PubMed ID: 24838241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
    Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
    J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of ApoE in HCV Infection and Comorbidity.
    Gong Y; Cun W
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green fluorescent protein-tagged apolipoprotein E: A useful marker for the study of hepatic lipoprotein egress.
    Takacs CN; Andreo U; Belote RL; Pulupa J; Scull MA; Gleason CE; Rice CM; Simon SM
    Traffic; 2017 Mar; 18(3):192-204. PubMed ID: 28035714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse hepatic cells support assembly of infectious hepatitis C virus particles.
    Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R
    Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses.
    Hueging K; Weller R; Doepke M; Vieyres G; Todt D; Wölk B; Vondran FW; Geffers R; Lauber C; Kaderali L; Penin F; Pietschmann T
    PLoS One; 2015; 10(7):e0134529. PubMed ID: 26226615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Landscape of protein-protein interactions during hepatitis C virus assembly and release.
    Matthaei A; Joecks S; Frauenstein A; Bruening J; Bankwitz D; Friesland M; Gerold G; Vieyres G; Kaderali L; Meissner F; Pietschmann T
    Microbiol Spectr; 2024 Feb; 12(2):e0256222. PubMed ID: 38230952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients.
    Nielsen SU; Bassendine MF; Burt AD; Martin C; Pumeechockchai W; Toms GL
    J Virol; 2006 Mar; 80(5):2418-28. PubMed ID: 16474148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture.
    Chang KS; Jiang J; Cai Z; Luo G
    J Virol; 2007 Dec; 81(24):13783-93. PubMed ID: 17913825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipids and HCV.
    Bassendine MF; Sheridan DA; Bridge SH; Felmlee DJ; Neely RD
    Semin Immunopathol; 2013 Jan; 35(1):87-100. PubMed ID: 23111699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread.
    Barretto N; Sainz B; Hussain S; Uprichard SL
    J Virol; 2014 May; 88(9):5050-61. PubMed ID: 24554660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity.
    Bankwitz D; Doepke M; Hueging K; Weller R; Bruening J; Behrendt P; Lee JY; Vondran FWR; Manns MP; Bartenschlager R; Pietschmann T
    J Hepatol; 2017 Sep; 67(3):480-489. PubMed ID: 28438690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors.
    Jiang J; Wu X; Tang H; Luo G
    PLoS One; 2013; 8(7):e67982. PubMed ID: 23844141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
    Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A
    Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle Formation.
    Puig-Basagoiti F; Fukuhara T; Tamura T; Ono C; Uemura K; Kawachi Y; Yamamoto S; Mori H; Kurihara T; Okamoto T; Aizaki H; Matsuura Y
    J Virol; 2016 Oct; 90(19):8464-77. PubMed ID: 27440892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.